Paper8360482
Humanization of an antibody directed against IgE.
Presta LG and 6 others. J Immunol, 1993. Cited by 338 papers, by iCite.
Cite this record
ConductScience Library. Humanization of an antibody directed against IgE. Papers, record 8360482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8360482
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Anti-Idiotypic | Major topic |
| Antibodies, Monoclonal | Major topic |
| Immunoglobulin E | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Humans | |
| Immunoglobulin Fab Fragments | |
| Immunoglobulin Variable Region | |
| Mice | |
| Models, Molecular | |
| Molecular Sequence Data | |
| Receptors, IgE | |
| Recombinant Fusion Proteins | |
| Structure-Activity Relationship |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT00604786 | The Effect of Omalizumab on Responses to Cat Allergen Challenge | Background | ClinicalTrials.gov | |
| NCT01003301 | The Effects of Omalizumab (Anti-IgE) on the Late-phase Response to Nasal Allergen Challenge | Background | ClinicalTrials.gov |
Cited by102
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 338 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42979487 | Key Players and Pathways of Mast Cell Activation in Urticaria. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42979487 | PubMed |
| 41875154 | Fab-Fc and Fab-Fab interactions of variable strength and valency contribute to the high concentration viscosity of IgG1 antibodies. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/41875154 | PubMed |
| 41813615 | A Link Between Allergy and Hematological Malignancies? Focus on Possible Mechanisms and the Potential Role of Biological Therapies. | Clin Transl Allergy | 2026 | https://conductscience.org/library/papers/41813615 | PubMed |
| 41660622 | Emerging diagnostic and therapeutic opportunities in food allergy. | Front Immunol | 2025 | https://conductscience.org/library/papers/41660622 | PubMed |
| 41394894 | Neutralizing serum IgE upregulates CD88 and CRTH2 expression on basophils in patients with asthma. | J Allergy Clin Immunol Glob | 2026 | https://conductscience.org/library/papers/41394894 | PubMed |
| 41316380 | Efficacy of Omalizumab against Japanese Cedar pollinosis in clinical practice. | Allergy Asthma Clin Immunol | 2025 | https://conductscience.org/library/papers/41316380 | PubMed |
| 40782271 | Autoallergy and what the Allergist Needs to know. | Curr Allergy Asthma Rep | 2025 | https://conductscience.org/library/papers/40782271 | PubMed |
| 40697948 | Omalizumab controls surface phenotypes of dendritic cells and monocytes in asthma. | J Allergy Clin Immunol Glob | 2025 | https://conductscience.org/library/papers/40697948 | PubMed |
| 40242148 | Omalizumab is ineffective in regulating proasthmatic serum cytokine and chemokine levels in nonresponders with high BMI. | J Allergy Clin Immunol Glob | 2025 | https://conductscience.org/library/papers/40242148 | PubMed |
| 40237828 | [Diagnosis and drug therapy of chronic rhinosinusitis]. | HNO | 2025 | https://conductscience.org/library/papers/40237828 | PubMed |
| 39660217 | YabXnization platform: A monoclonal antibody heterologization server based on rational design and artificial intelligence-assisted computation. | Comput Struct Biotechnol J | 2024 | https://conductscience.org/library/papers/39660217 | PubMed |
| 39598410 | Therapies for Chronic Spontaneous Urticaria: Present and Future Developments. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/39598410 | PubMed |
| 39179708 | Allosteric inhibition of IgE-FcεRI interactions by simultaneous targeting of IgE F(ab')2 epitopes. | Commun Biol | 2024 | https://conductscience.org/library/papers/39179708 | PubMed |
| 39158477 | Therapeutic monoclonal antibodies in allergy: Targeting IgE, cytokine, and alarmin pathways. | Immunol Rev | 2024 | https://conductscience.org/library/papers/39158477 | PubMed |
| 39071162 | Frequency of Severe Asthma and Its Clinical Phenotypes at the Asthma Clinic in One of the Largest Sudanese Tertiary Pediatric Hospitals: A Cross-Sectional Hospital-Outpatient-Based Study. | J Asthma Allergy | 2024 | https://conductscience.org/library/papers/39071162 | PubMed |
| 39028186 | Modulation of the high concentration viscosity of IgG1 antibodies using clinically validated Fc mutations. | MAbs | 2024 | https://conductscience.org/library/papers/39028186 | PubMed |
| 37776480 | Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status. | Dermatol Ther (Heidelb) | 2023 | https://conductscience.org/library/papers/37776480 | PubMed |
| 37764213 | Therapeutic Antibodies in Medicine. | Molecules | 2023 | https://conductscience.org/library/papers/37764213 | PubMed |
| 36755957 | Self-reactive IgE and anti-IgE therapy in autoimmune diseases. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/36755957 | PubMed |
| 36359393 | Therapeutical Targets in Allergic Inflammation. | Biomedicines | 2022 | https://conductscience.org/library/papers/36359393 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IGHE | 3497 | PubTator's text mining | https://conductscience.org/library/genes/3497 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8360482
GET https://conductscience.org/api/papers/v1/8360482/cited_by?page=2